or SA, 17 for which few clinically well-characterized cohorts are available. 18 Our aim in the present study was to identify the gene pathways that are deregulated in children with SA. Therefore we analyzed gene expression in peripheral blood leukocytes from children with SA (n 5 13) and controlled persistent asthma (CA; n 5 15), as well as age-matched healthy control subjects (CTRLs; n 5 9). We used Cap Analysis of Gene Expression (CAGE), a technology based on next-generation sequencing that quantitatively measures gene expression for individual transcription start sites (TSSs), including mRNAs and long noncoding RNAs. 19 The asthmatic children were selected from Swedish Search, a national multicenter, cross-sectional study that aims to identify children with problematic severe asthma and characterize those who are difficult to treat or resistant to therapy. 20 Although these samples had previously been analyzed with expression microarrays, 21 we reasoned that the promoter-level resolution of CAGE sequencing data and the unbiased detection of novel genes and alternative promoters could provide new and interesting information.
METHODS
Children with CA (n 5 15) and SA (n 5 13) were selected from the Swedish Search study; details on inclusion criteria and clinical examination procedures are described elsewhere. 20, 21 CTRLs (n 5 9) were recruited at Astrid Lindgren Children's Hospital, Stockholm, Sweden, from children admitted for elective surgical procedures unrelated to asthma. Buffy coat isolation from blood samples and RNA extraction were described previously. 21 For statistical analysis of clinical parameters, normally distributed data are summarized by means and SDs and compared by using the Student t test. Nonnormally distributed data are presented as medians and interquartile ranges and compared with the Mann-Whitney U test. A comprehensive description of the methods used in this study is provided in the Methods section in this article's Online Repository at www. jacionline.org. Primers for validation of novel TSSs are listed in Table E1 in this article's Online Repository at www.jacionline.org. Informed consent was obtained from all participating children and their parents, and the study was approved by the local ethics committee.
RESULTS
We analyzed the transcriptome of peripheral blood leukocytes from children with CA (n 5 15) and those with SA (n 5 13), as well as age-matched CTRLs (n 5 9) using CAGE sequencing. The asthmatic children were selected from the Swedish Search study, 20 and all cases of SA had been classified as SA in the absence of any identified aggravating factors. Most clinical variables did not differ between the CA and SA groups, but children with SA had significantly stronger responses to methacholine provocation and increased blood neutrophil counts compared with those with CA (Table I) , as previously reported in children with severe asthma. 22 Leukocyte cell counts are provided for individual samples in Table E2 19 Expression for a particular TSS is estimated by grouping nearby sequencing reads (tags) after mapping to the human genome to tag clusters (TCs) and counting the number of reads within each cluster. Sequencing library sizes are shown in Table E2 . We limited expression analysis to a set of 45635 TCs that were detected by at least 3 reads in at least 9 samples (ie, the size of the smallest sample group). When compared with GENCODE 23 transcript annotation, 49% of the TCs mapped within 500 bp of a known TSS, and another 24% mapped in exons of known genes. A further 27% of the TCs were not located within exons of known coding or noncoding genes; these might represent novel genes or transcript isoforms. TC annotation is summarized in Fig E2 in this article's Online Repository at www.jacionline. org.
Children with CA and those with SA have distinct gene expression profiles and cluster separately
We performed differential expression analysis for all pairwise comparisons: children with CA versus CTRLs, children with SA versus CTRLs, and children with SA versus those with CA. A total of 1305 TCs were differentially expressed with a BenjaminiHochberg-adjusted P value of less than .1 in any comparison, and 1029 of these mapped to 816 unique gene symbols (ie, some genes had >1 cluster). The remaining TCs were intergenic, intronic, or antisense to known transcripts. Hierarchical clustering of the samples based on differentially expressed TCs clearly separated the sample groups, with the exception of a single CTRL sample that clustered with the SA group (Fig 1) . Statistically significant TCs with GENCODE transcript annotation are provided in Tables E3-E5 in this article's Online Repository at www. jacionline.org.
These results imply that differences in the underlying disease biology of CA and SA are reflected as distinct molecular fingerprints. However, because we measured gene expression for a complex population of leukocytes, the profiles also reflect differences in cell composition between sample groups, such as the significantly increased neutrophil counts in children with SA (Table I ). Therefore we analyzed differential expression further using the generalized linear model (GLM) methods in edgeR, 24 applying a model that incorporated both sample groups and neutrophil, eosinophil, and lymphocyte blood counts as fractions of the total number of white blood cells. This adjusted the expression levels for differences in cell counts among samples but also removed TCs that varied with both sample groups and neutrophil counts, resulting in a conservative set of TCs that were differentially expressed, irrespective of cell composition. A total of 680 TCs were differentially expressed, with an adjusted P value of less than .1 in any comparison, and 503 of these mapped to 460 unique gene symbols. Hierarchical clustering and Venn diagrams illustrating the overlap between the 2 differential expression analyses are shown in Figs E3 and E4 in this article's Online Repository at www. jacionline.org, respectively. Statistically significant TCs with GENCODE transcript annotation are provided in Tables E6-E8 in this article's Online Repository at www.jacionline.org.
Because our patient groups were comparatively small, we assessed statistical power for our current sample size and false discovery rates and obtained consistent power predictions of between 0.4 and 0.5. By randomizing sample group labels, we found the rate of false-positive results among differentially expressed TCs to be practically zero. Combining these analyses (see Figs E5 and E6 in this article's Online Repository at www. jacionline.org), we conclude that although identification of marker genes between disease groups is somewhat limited by the statistical power at these sample sizes, we can still identify a stable set of biomarker genes.
Genes differentially expressed between children with SA and those with CA also distinguish severe from nonsevere asthma in adults We tested these results on an independent set of publicly available gene expression microarray data for CD4 1 and CD8
1
T cells from adults with severe and nonsevere asthma. 16 The original study found activation of CD8
1 T cells in patients with severe asthma but only minor differences for CD4 1 cells and no significant difference between patients with nonsevere asthma and CTRLs. We selected all available microarray probes for GENCODE transcripts with a differentially expressed TC in our analysis (1537 probes for 698 of 1305 TCs from pairwise comparisons between sample groups) and clustered the expression profiles of the 2 T-cell types separately. Although our set of differentially expressed transcripts was derived from mixed leukocytes from children, it could still separate CD8
1 T cells from adults with severe and those with nonsevere asthma, and results were similar for differentially expressed transcripts from the GLM analysis (see Figs E7 and E8 in this article's Online Repository at www.jacionline.org). Bootstrapping analysis of the stability of the separation between groups is shown in Fig E9 in this article's Online Repository at www.jacionline.org. These results suggest that the differences in gene expression reflect the underlying disease dysregulation and that there are molecular similarities between SA in children and severe asthma in adults. It also hints that some of the differential expression we see is likely to depend on CD8 1 rather than CD4 1 T cells. Finally, it shows that results from CAGE sequencing can be transferred to another technology and that these transcripts are applicable as markers in another sample set.
Increased activity of natural killer cells and genes involved in leukocyte migration in children with SA
To explore the biology underlying the differentially expressed TCs, we annotated them with gene symbols and searched for Gene Ontology (GO) term and pathway (Kyoto Encyclopedia of Genes and Genomes [KEGG]) enrichment using GOseq. 25 Table II lists a selection of significant terms (adjusted P < .05) and their associated genes. Because some of these might result from cell count differences, we also analyzed enrichment for the GLM analysis of differential expression. Few GO terms and KEGG pathways were significantly enriched in this analysis, partly because of the smaller number of differentially expressed genes. Most likely, this is also because many differences found before adjusting for leukocyte cell counts represent differences in sample composition. Categories that retain significance (adjusted P < .1) are marked in Table II . Both children with CA and those with SA displayed activation of genes involved in natural killer (NK) cell-mediated cytotoxicity, but the differentially expressed genes differed. Fig E10 in this article's Online Repository at www.jacionline.org shows differences in NK cell signaling between the 2 patient groups in a KEGG pathway diagram.
Experimental validation of novel transcripts and alternative TSSs
Using CAGE sequencing, we could also detect novel transcripts and alternative TSSs. Combined bioinformatic analysis and manual curation identified a high-confidence set of 13 candidate novel TSSs for experimental validation (Table III) . Ten of these could be detected by using RT-PCR for 2 CTRL samples, and all 10 were further confirmed by means of Sanger sequencing (see Fig E11 in 
Comparison of differentially expressed TCs with genetic associations in asthmatic patients
We compared the genomic coordinates of our differentially expressed TCs with single nucleotide polymorphisms (SNPs) significantly associated with asthma in genome-wide association studies. HaploReg v2 28 was used to identify linkage disequilibrium (LD) blocks for 62 SNPs with genome-wide significant association with asthma from 17 studies. 29 Two differentially expressed TCs from the classical differential expression analysis overlapped LD blocks associated with asthma in European populations that were located in the IL-6 receptor (IL6R) 30 and IL-2 receptor b (IL2RB) 31 genes (see Tables E9 and E10 in this article's Online Repository at www.jacionline.org). Both TCs were upregulated 3-fold in children with SA compared with those with CA but were not differentially expressed between children with CA and CTRLs. A third TC in absent in melanoma 2 (AIM2) overlapped an LD block associated with asthma in subjects of African descent. 32 Furthermore, 2 differentially expressed TCs were in the genes GRB2-associated binding protein 1 (GAB1) 33 and RAR-related orphan receptor A (RORA), 31 which have been previously associated with asthma, although not within the association blocks. Only the TC in RORA was significantly differentially expressed in the cell count-adjusted (GLM) analysis, which also included 2 differentially expressed TCs in PY-HIN1 and IFI16, both of which were located in the same LD block as AIM2. 32 Expression levels for these clusters are shown in Fig E14 in this article' s Online Repository at www. jacionline.org. Additionally, an SNP 225 bp upstream of the cluster in IL2RB, rs228954, overlaps a DNase I hypersensitivity signal 34 and is predicted to change a binding motif for the peroxisome proliferator-activated receptors. 35, 36 Interestingly, rs2284033, an SNP located 1.6 kb upstream of the cluster, is predicted to alter a binding site for RORA. The small overlap between differentially expressed TCs and associated genetic variants supports the concept that transcriptional dysregulation typically occurs downstream of the causal factors at disease onset.
37
Distinct transcription factor networks regulate gene expression in children with CA and those with SA Because CAGE measures gene expression by sequencing TSSs, the data are well suited for promoter analysis. We applied Motif Activity Response Analysis (MARA) 38 to model the regulatory networks underlying gene expression profiles. MARA combines prediction of transcription factor (TF) binding sites with mathematic modeling of changes in gene expression to calculate the global importance of TF binding sites for driving gene expression in a given sample. We analyzed proximal promoter regions from 300 bp upstream to 100 bp downstream of TCs and a wider promoter region from 1 kb upstream to 200 bp downstream. We limited the analysis to TCs near known TSSs plus our high-confidence set of novel TSSs and again used linear models to adjust for sample leukocyte composition. This produces a conservative estimate of differences between sample groups, excluding also motifs varying with both group and cell counts. This adjustment is especially important because we aim to infer regulatory relationships between TFs and target genes occurring within a cell. The top 10 significant motifs (adjusted P < .1) from pairwise comparisons of motif activities between sample groups are shown in Table IV for the wider promoter region (see Table E11 in this article's Online Repository at www.jacionline.org for the proximal promoter region). Box plots illustrating motif activities within sample groups are shown in Figs E15-E17 in this article's Online Repository at www.jacionline.org. Expression profiles of the TFs corresponding to the motifs in Table IV are shown in Fig E18 in this article' s Online Repository at www. jacionline.org for sorted leukocyte populations from the FANTOM5 project.
27 Fig 3 shows the regulatory network for motifs with significantly different activity between children with CA and those with SA. Differences in gene expression between these 2 types of asthma appear to be determined by 2 internally highly connected TF modules. One of these has higher activity in children with SA than in those with CA and includes motifs for TFs, such as GTF2I, HIC1, PAX5, and the MYF and TFAP2 families. The other module, which includes motifs for TFs, such as ZNF148 and the NFY family, has decreased activity in children with SA compared with those with CA. Notably, motif activity for the glucocorticoid receptor (NR3C1) was also lower in children with SA. Regulatory networks for the proximal promoter region and the other (children with CA vs CTRLs and children with SA vs CTRLs) are shown in Figs E19-E23 in this article's Online Repository at www. jacionline.org.
GO and pathway analyses highlight the roles of individual TFs
To understand the function of these TFs in our samples, we analyzed GO term and KEGG pathway enrichment for their predicted target gene sets. For example, the motif for ZNF238 was associated with genes involved in mitogen-activated protein kinase (MAPK) signaling, including nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NFKB1). This motif has increased activity in children with CA compared with CTRLs and even higher activity in children with SA. The proximal promoter regions of genes involved in the MAPK and Jun kinase cascades were also enriched for the TFAP2B motif, which has increased activity in children with SA versus those with CA. Interestingly, the ELK1,4_GABP{A,B1} motif, which has decreased motif activity in both children with CA and those with SA versus CTRLs, was found in the promoters of a large number of ribosomal proteins, as well as proteins involved in RNA transport and the spliceosome. Coordinates represent the first nucleotide of the transcript, with the genomic strand in parentheses. NS, Not significant; tpm, tags per million reads. *Significantly differentially expressed also after adjustment for cell counts. 
DISCUSSION
We analyzed gene expression using CAGE in peripheral blood leukocytes from children with CA, children with SA, and CTRLs. We found that they have distinct gene expression profiles with implications for disease biology and that these differences are partly explained by the underlying regulatory TF networks. Gene network analysis identified decreased glucocorticoid receptor signaling and increased activity of the MAPK and Jun kinase cascades in children with SA. Many putative novel transcripts and TSSs were differentially expressed, and 77% (10/13) of those selected for experimental validation could be detected by using RT-PCR.
Pairwise comparison between sample groups identified 1305 significantly differentially expressed TCs, 1029 of which matched 816 known genes. This is similar to the number of differentially expressed genes in microarray data previously reported for a cohort in which these samples were included. 21 Although the microarray study only identified activation of NK cell-mediated cytotoxicity in children with CA, we here found upregulation of different gene sets within this pathway for both children with CA and those with SA compared with CTRLs.
Because the increased blood neutrophil count in children with SA is likely to affect gene expression profiles, we also analyzed the CAGE data using GLMs to account for differences in leukocyte composition. Some processes, including upregulation of NK cell-mediated cytotoxicity and leukocyte migration, as well as downregulation of ribosomal proteins, in children with SA remained significant, even after adjustment.
The overlap of significantly differentially expressed genes between CAGE and microarray analysis was surprisingly small (approximately 5%). Although earlier work also found relatively large differences between these methods, 39 a comparison of log 2 fold changes irrespective of P values demonstrated a reassuring overrepresentation of concordant versus discordant changes in gene expression (see Table E12 in this article's Online Repository at www.jacionline.org). One contrasting finding is the upregulation of bitter taste receptor genes in children with SA in the microarray study. 21 These genes are localized in a cluster on chromosome 12, overlapping the PRR4/PRH1 genes, and alternative splicing of the PRR4/PRH1 transcripts results in multiple isoforms encompassing different bitter taste receptor genes. 23 We found a few CAGE tags within this locus, but a strong TSS signal closely upstream of PRR4/PRH1, which might be the promoter for the overlapping bitter taste receptors. In agreement with the microarray study, we found that this promoter is significantly overexpressed in children with SA compared with CTRLs. 21 Irrespective of the differences, we see a number of advantages of using CAGE over microarrays: (1) a markedly improved separation of sample groups by differentially expressed TCs, as shown by using hierarchical clustering; (ii) the ability to explore transcriptional complexity, leading to identification of differentially expressed novel TSSs; and (iii) sensitive detection and reliable quantification of coding and noncoding transcripts, where especially the latter are often lowly expressed.
The current literature contains little data on severe asthma for comparison, but a recent study on adults reported activation of CD8 1 but not CD4 1 T cells in patients with severe asthma, whereas patients with nonsevere asthma did not differ from CTRLs. 16 The CD8 1 T cells from patients with severe and those with nonsevere asthma could also be separated by clustering on both of our sets of differentially expressed marker transcripts. Interestingly, both of the cited studies reported extensive deregulation of noncoding RNAs in patients with severe asthma. 16, 21 Three of our 10 validated novel transcripts are putative long noncoding RNAs: one TSS upstream of an annotated long intergenic noncoding RNA (lincRNA) and 2 antisense transcripts. The first TSS was upregulated in children with SA, even after adjustment for cell counts. GENCODE-annotated noncoding RNAs upregulated in patients with SA included nuclear paraspeckle assembly transcript 1 (NEAT1) and PINT (AC058791.2), a lincRNA recently associated with p53 signaling. 40 Because asthma primarily affects the airways, it would be informative to analyze gene expression in cells from the respiratory tract, including inflammatory cells, bronchial epithelium, and smooth muscle. Bronchoscopies, including bronchial biopsy specimens, were not needed for the diagnosis of asthma, and the procedure would neither have been easy nor ethically defensible for these children, especially not for patients with severe asthma. Here we instead used total leukocytes from peripheral blood, a sample source that is easy A negative score implies lower motif activity in the first group, and a positive score implies higher activity (see the Methods section in this article's Online Repository). {core}, Core promoter element; {dimer}, protein dimer.
FIG 3.
MARA identifies the TF network underlying differential gene expression between children with CA and those with SA, which are here significant motifs in the promoter region (21000 to 1200 bp). Node color corresponds to fold change (blue, lower motif activity in patients with SA; red, higher activity), and node size is inversely proportional to P value. Edge color reflects gene-specific motif activity (darker equals higher activity [ie, stronger regulatory effect]). Target genes are represented by green circles for TFs, and yellow circles for other genes.
to obtain and store and well suited for biomarker development. These data provide a wealth of information on the blood transcriptome that could be expanded, such as through studies of alternative promoter use and functional testing of novel transcripts and transcript isoforms. However, the different results from conventional and GLM differential expression analysis stress the importance of appropriately handling differences in sample cell composition when sorted cell populations are unavailable. In summary, the clear separation of children with CA and those with SA shows the promise of gene expression profiling for the development of biomarkers given precisely posed clinical questions and appropriate validation cohorts. Differences in the disease biology of the 2 groups, as revealed by differential expression of both known and novel transcripts, support the need for novel therapeutic approaches.
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Key messages
d Circulating leukocytes from children with CA and those with SA have distinct gene expression profiles.
d Gene network analysis identified decreased glucocorticoid receptor signaling and increased activity of the MAPK and Jun kinase cascades in children with SA.
d The results suggest that it would be possible to develop molecular biomarkers for SA and support the need for novel therapeutic approaches in this group of patients.
